[1]
|
P. F. Weller and G. J. Bubley, “The Idiopathic Hypereosinophilic Syndrome,” Blood, Vol. 83, No. 10, 1994, p. 2759.
|
[2]
|
F. Roufosse, E. Cogan and M. Goldman, “Recent Advances in Pathogenesis and Management of Hypereosinophilic Syndromes,” Allergy, Vol. 59, No. 7, 2004, pp. 673-689. doi:10.1111/j.1398-9995.2004.00465.x
|
[3]
|
A. D. Klion, B. S. Bochner, G. J. Gleich, et al., “Approaches to the Treatment of Hypereosinophilic Syndromes: A Workshop Summary Report,” Journal of Allergy and Clinical Immunology, Vol. 117, No. 6, 2006, pp. 1292-1302. doi:10.1016/j.jaci.2006.02.042
|
[4]
|
J. Sheikh and P. F. Weller, “Clinical Overview of Hypereosinophilic Syndromes,” Immunology and Allergy Clinics of North America, Vol. 27, No. 3, 2007, pp. 333355. doi:10.1016/j.iac.2007.07.007
|
[5]
|
V. Ambarus and A. Cosovanu, “The Evolutionary Characteristics of the Hypereosinophilic Syndrome,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Lasi’S, Vol. 102, No. 1-2, 1998, pp. 69-75.
|
[6]
|
J. L. Motellon, C. Bernis, A. Garcia-Sanchez, E. Gruss and J. A. Traver, “Renal Involvement in the Hyper-Eosinophilic Syndrome,” Nephrology Dialysis Transplantation, Vol. 10, No. 3, 1995, pp. 401-403.
|
[7]
|
A. S. Fauci, J. B. Harley, W. C. Roberts, V. J. Ferrans, H. R. Gralmick and B. H. Bhorson, “The Idiopathic Hypereosinophilic Syndrome: Clinical, Pathophy-Siologic and Therapeutic Considerations,” Annals of Internal Medicine, Vol. 97, No. 1, 1982, pp. 78-92.
doi:10.7326/0003-4819-97-1-78
|
[8]
|
I. Navarro, J. Torras, M. Gomà, J. M. Cruzado and J. M. Grinyó, “Renal Involvement as the First Manifestation of Hypereosinophilic Syndrome,” Clinical Kidney Journal, Vol. 2, No. 5, 2009, pp. 379-381.
|
[9]
|
C. J. Spry, J. Davies, P. C. Tai, E. G. Oslen, C. M. Oakley and J. F. Goodwin, “Clinical Features of Fifteen Patients with the Hypereosinophilic Syndrome,” Journal of Nuclear Medicine, Vol. 205, No. 52, 1983, pp. 1-2.
|
[10]
|
F. Bulucu, C. Can, V. Inal, Y. Baykal and S. Erikci, “Renal Involvement in a Patient with Idiopathic Hypereosinophilic Syndrome,” Clinical Nephrology, Vol. 57, No. 2, 2002, pp. 171-172.
|
[11]
|
M. Frigui, M. B. Hmida, M. Jallouli, M. Kechaou, F. Frikha and Z. Bahloul, “Membranousglomerulopathy Associated with Idiopathic Hypereosinophilic Syndrome,” Saudi Journal of Kidney Diseases and Transplantation, Vol. 21, No. 2, 2010, pp. 320-322.
|
[12]
|
Y. J. Choi, J. D. Lee, K. H. Yang, B. K. Kim, B. K. Bang and S. I. Shim, “Immunotactoidglomerulopathy Associated with Idiopathic Hypereosinophilic Syndrome,” American Journal of Nephrology, Vol. 18, 1998, pp. 337-343.
doi:10.1159/000013362
|
[13]
|
M. J. Chusid, D. C. Dale, B. C. West and S. M. Wolff, “The Hypereosinophilic Syndrome: Analysis of Fourteen Cases with Review of the Literature,” Medicine, Vol. 54, No. 1, 1975, p. 27.
|
[14]
|
P. Richardson, G. Dickinson, S. Nash, L. Hoffman, R. Steingard and M. Germain, “Crescentic Glome-Rulonephritis and Eosinophilic Interstitial Infiltrates in a Patient with Hypereosinophilic Syndrome,” Postgraduate Medical Journal, Vol. 71, 1995, pp. 175-178.
doi:10.1136/pgmj.71.833.175
|
[15]
|
C. P. Guidicelli, F. Didelot, C. Duvic, J. Desrame, M. Herody and G. Nedelec, “Eosinophilia and Renal Pathology,” Medicine Tropicale, Vol. 58, Suppl. 4, 1998, pp. 477481.
|
[16]
|
U. Schnetzke, T. Bossert, et al., “Drug-Induced Lymphadenopathy with Eosinophilia and Renal Failure Mimicking Lymphoma Disease: Dramatic Onset of DRESS Syndrome Associated with Antibiotic Treatment,” Annals of Hematology, Vol. 90, No. 11, 2011, pp. 1353-1355.
|
[17]
|
R Talwar, S. C. Dash, et al., “A Case of Chronic Myeloid Leukemia Complicated with Minimal Change Nephrotic Syndrome,” Acta Haematologica, Vol. 109, No. 2, 2003, pp. 101-103.
|
[18]
|
M. L. F. van Velthuysen and S. Florquin, “Glomerulopathy Associated with Parasitic Infections,” Clinical Microbiological Review, Vol. 13, No. 1, 2000, pp. 55-66.
|
[19]
|
B. S. Kasinath and E. J. Lewis, “Eosinophilia as a Clue to the Diagnosis of Atheroembolic Renal Disease,” Archives of Internal Medicine, Vol. 147, No. 8, 1987, pp. 13841385.
|
[20]
|
P. U. Ogbogu, B. S. Bochner, J. H. Butterfield, et al., “Hypereosinophilic Syndrome: A Multicenter, Retrospective Analysis of Clinical Characteristics and Response to Therapy,” Journal of Allergy and Clinical Immunology, Vol. 124, No. 6, 2009, pp. 1319-1325.
doi:10.1016/j.jaci.2009.09.022
|
[21]
|
A. B. Kay and A. D. Lion, “Anti-IL-5 Therapy for Asthma and Hypereosinophilicsyndrome,” Immunology and Allergy Clinics of North America, Vol. 24, No. 4, 2004, pp. 645-666. doi:10.1016/j.iac.2004.06.007
|
[22]
|
M. E. Rothenber, et al., “Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab,” New England Journal of Medicine, Vol. 358, 2008, pp. 12151228. doi:10.1056/NEJMoa070812
|